Filter Results :

Your search for Diseases returned 200 reports

Sort by


Respiratory Diseases Drugs Market Global Report 2017

17 Jul 2017  |  Published by:  Business Research Company
Respiratory Diseases Drugs Market Global Report 2017  Including: Anti-Asthmatics And COPD Drugs Market, Cough And Cold Preparations, Covering: GlaxosmithKline, Novartis AG, Pfizer Inc., Boehringer Ingelheim, and AstraZeneca PLCTop competitors in the respiratory diseases drugs market are strateg...

$ 4,000.00

Read More

Human Papillomavirus Associated Diseases - Pipeline Insights, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “Human Papillomavirus Associated Diseases (HPV-AD) - Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs and vaccines for this area. This report also provides information on the therapeutic development for the Human Papillomavirus (HPV) Associated Di...

$ 1,500.00

Read More

Graves Diseases - Pipeline Review, H1 2017

27 Jun 2017  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Pipeline Review, H1 2017, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape.Graves' disease is an immune system disorder that results in the overproduction o...

$ 2,000.00

Read More

Inflammatory Skin Diseases Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'Inflammatory Skin Diseases- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for ...

$ 2,000.00

Read More

Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Graves Diseases Report is to understand the mark...

$ 2,000.00

Read More

Inflammatory Skin Diseases-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ Inflammatory Skin Diseases-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Inflammatory Skin Diseases. The DelveInsight’sReport covers the product profiles in various stages of development including Disco...

$ 1,250.00

Read More

Liver Diseases-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
SUMMARY'Liver Diseases-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Liver Diseases. This report provides information on the the...

$ 1,250.00

Read More

Motor Neurone Diseases-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ Motor Neurone Diseases-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Motor Neurone Diseases. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pr...

$ 1,250.00

Read More

IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Forecast to 2022

08 May 2017  |  Published by:  MarketsandMarkets
The IVD market in BRIC is expected to reach USD 15.71 billion by 2022 from USD 10.60 billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the num...

$ 5,650.00

Read More

Drugs for Neglected Diseases initiative - Pharmaceuticals & Healthcare - Deals and Alliances Profile

26 Apr 2017  |  Published by:  GlobalData
SummaryDrugs for Neglected Diseases initiative (DNDi) is a research center that discovers and develops new drugs. The center develops therapeutics for the treatment of various diseases. It offers treatments which include ASAQ, ASMQ, NECT, SSG&PM and pediatric benznidazole. DNDi also offers products ...

$ 250.00

Read More

Global Sexually Transmitted Diseases Partnering 2010-2017

01 Apr 2017  |  Published by:  CurrentPartnering
Provides understanding and access to the sexually transmitted diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Sexually Transmitted Diseases Partnering Terms and Agreements since 2010 report provides understanding and access to partne...

$ 1,495.00

Read More

Global Orphan Diseases Partnering 2010-2017: Deal trends, players and financials

01 Apr 2017  |  Published by:  CurrentPartnering
The Global Orphan Diseases Partnering 2010-2017: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies.Global Orphan Diseases Partnering 2...

$ 2,995.00

Read More

Global Infectious Diseases Partnering 2010-2017: Deal trends, players and financials

01 Apr 2017  |  Published by:  CurrentPartnering
Global Infectious Diseases Partnering 2010-2017: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.Global Infectious Diseases Partnering 20...

$ 3,495.00

Read More

KSPH - Kaifeng Hospital for Infectious Diseases - Henan Project Profile

20 Mar 2017  |  Published by:  Timetric
Synopsis"KSPH – Kaifeng Hospital for Infectious Diseases – Henan Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, t...

$ 75.00

Read More

The Top 250 Developers of In-Vitro Diagnostics Tests for Cancer, Cardiovascular & Infectious Diseases

10 Mar 2017  |  Published by:  Research Facts
Did you know?- Daniella Cramp is Global President, Cardiometabolic at Alere Inc..- Beijing Wantai Biological Pharmacy’s Beijing plant is the largest manufacturing base for the production of infectious diseases diagnostics in China.- MDxHealth was the winner of the 2016 Frost & Sullivan Global Pr...

$ 2,250.00

Read More
Total 200 records.